Stephen Blacklow
Professor and Chair
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Mesial ( a.k.a., medial) temporal lobe epilepsy (MTLE) is the most common focal epilepsy 1,2 and, in drug-resistant cases, is treated by surgical removal of the anterior temporal lobe, which often shows neuronal loss and gliosis consistent with hippocampal sclerosis (HS) 2 . MTLE with HS has minimal contribution from germline genetic variation 3 , and is associated with prior precipitating insults such as prolonged childhood seizures and head trauma 4–6 . Somatic variants in Ras-MAPK pathway genes were recently reported in a few MTLE surgical specimens 7,8 , but their prevalence, clinical relevance, and underlying biological mechanisms remain unknown. Targeted duplex sequencing of hippocampal DNA from 462 surgical resections revealed significant enrichment of deleterious somatic variants in MTLE versus controls, with >40% of MTLE specimens harboring activating Ras-MAPK variants in PTPN11 , NF1 , BRAF , KRAS , and twelve genes not previously associated with focal epilepsy. Eight Ras-MAPK genes showed positive clonal selection in MTLE. Increased somatic variant burden predicted worse surgical outcome. Somatic Ras-MAPK variants at ultra-low (<0.5%) variant allele fractions were associated with older seizure onset and HS pathology, supporting a late prenatal or postnatal origin. Ras-MAPK variants in MTLE were enriched in cells derived from hippocampal progenitors—neurons, astrocytes, oligodendrocytes—in line with the known neuronal hyperexcitability and seizures induced by Ras-MAPK overactivation 9,10 ; in contrast, Alzheimer disease hippocampi exhibited microglial enrichment of Ras-MAPK variants, consistent with prior reports 11 . Single-nucleus RNA sequencing showed increased expression of Ras-MAPK genes in neurons and upregulation of pathways mediating neurogenesis and neural development in MTLE. Functional validation of novel, recurrent PTPN11 variants confirmed gain-of-function, while cellular modeling in induced pluripotent stem cells demonstrated proliferative/survival advantages for mutant cells in mosaic culture. Overall, our data suggest that somatic Ras-MAPK variants and acquired risk factors may converge on clonal competition in the hippocampus to modulate epilepsy risk.
Year:
2026
Mind bomb 1 (MIB1) is a RING E3 ligase that ubiquitinates Notch ligands, a necessary step for induction of Notch signaling. The structural basis for binding of the JAG1 ligand by the N-terminal region of MIB1 is known, yet how the ankyrin (ANK) and RING domains of MIB1 cooperate to catalyze ubiquitin transfer from E2∼Ub to Notch ligands remains unclear. Here, we show that the third RING domain and adjacent coiled coil region of MIB1 (ccRING3) drives MIB1 dimerization and that ubiquitin transfer activity of MIB1 relies solely on RING3. We report x-ray crystal structures of a UbcH5B-ccRING3 complex as a fusion protein and of the ANK region. Directly tethering the N-terminal region to ccRING3 forms a minimal MIB1 protein, which is sufficient to induce a Notch response in receiver cells. Together, these studies define the functional elements of an E3 ligase needed for ligands to induce a Notch signaling response.
Year:
2024
Collaborators (9)
Vincent Navarro
co-Head of a researchTeam 'Dynamics of epileptic networks and neuronal excitability'
Institut du Cerveau et de la Moelle Épinière
Robert Richardson
Director, Functional Neurosurgery
Massachusetts General Hospital
Yue Huang
Principal Investigator
Harvard Medical School
Taufik A Valiante
Neurosurgeon
University Health Network
Ingrid Scheffer
Chair of Paediatric Neurology
University of Melbourne
Samuel Berkovic
University of Melbourne
Piero Perucca
Professor of Adult Epilepsy
University of Melbourne
Maria Kontaridis
Executive Director, Gordon K Moe Professor
-
Rani Sarkis
Associate Professor
Harvard Medical School
Make your next move.
Prepare your application
Review drafts before you send them.